Revolution Medicines (RVMDW) Other financing activities (2019 - 2026)
Revolution Medicines (RVMDW) posted quarterly Other financing activities of $12.2 million for Q1 2026, up 1220800.0% year-over-year from N/an in Q1 2025, and down 13.78% quarter-over-quarter from $14.2 million in Q4 2025.
Revolution Medicines (RVMDW) Other financing activities (2019 - 2026) Analysis & Trends
Revolution Medicines' Other financing activities history runs 8 years deep, the most recent figure standing at $12.2 million for Q1 2026.
- In Q1 2026, Other financing activities rose 1220800.0% year-over-year to $12.2 million; the TTM figure through Mar 2026 stood at $33.3 million (down 65.06% YoY), while the FY2025 annual figure was $21.1 million, down 77.85% from the prior year.
- Other financing activities for Q1 2026 stood at $12.2 million, down from $14.2 million in the prior quarter.
- The five-year high for Other financing activities was $87.3 million in Q4 2024, with the low at -$2.0 million in Q4 2023.
- The 5-year median for Other financing activities is $894000.0 (2022), against an average of $8.1 million.
- The sharpest annual moves came in 2023 and 2026: Other financing activities tumbled 354.57% in 2023, then surged 1220800.0% in 2026.
- Revolution Medicines' Other financing activities stood at $777000.0 in 2022, then sank by 354.57% to -$2.0 million in 2023, then soared by 4512.08% to $87.3 million in 2024, then plunged by 83.77% to $14.2 million in 2025, then declined by 13.78% to $12.2 million in 2026.
- Business Quant data shows RVMDW's Other financing activities at $12.2 million in Q1 2026, $14.2 million in Q4 2025, and $4.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Revolution Medicines | 2.45 Bn | 2.45 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.84 Mn |
| Jun 30, 2026 | 28.84 Mn |
| Mar 31, 2026 | 12.21 Mn |
| Mar 31, 2026 | 12.21 Mn |
| Dec 31, 2025 | 14.16 Mn |
| Dec 31, 2025 | 14.16 Mn |
| Sep 30, 2025 | 4.15 Mn |
| Sep 30, 2025 | 4.15 Mn |
| Jun 30, 2025 | 2.83 Mn |
| Jun 30, 2025 | 2.83 Mn |
| Mar 31, 2025 | 1,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 87.27 Mn |
| Dec 31, 2024 | 87.27 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 5.15 Mn |
| Jun 30, 2024 | 5.15 Mn |
| Dec 31, 2023 | -1.98 Mn |
| Dec 31, 2023 | -1.98 Mn |